Company
BioInvent
UNLEASHING IMMUNITY TO FIGHT CANCER
- Business model
- B2B
- Legal name
- BioInvent International AB
Claim, correct or request removal
Record updated 28 September 2026
About
BioInvent is a clinical-stage company focused on the development of novel, first-in-class immuno-modulatory antibodies for the treatment of cancer.
Products
- Web
- BI-1206
- Web
- BI-1607
- Web
- BI-1808
- Web
- BI-1910
Loading relationship preview